WallStSmart
CELC

Celcuity LLC

NASDAQ: CELC · HEALTHCARE · BIOTECHNOLOGY

$119.00
-0.89% today

Updated 2026-04-29

Market cap
$5.80B
P/E ratio
P/S ratio
EPS (TTM)
$-3.79
Dividend yield
52W range
$10 – $129
Volume
0.7M

WallStSmart proprietary scores

25
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C
5.3
Quality
C+
3.0
Profitability
D
5.0
Valuation
C+
3/9
Piotroski F-Score
Weak
-2.3
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target
$130.55
+9.71%
12-Month target
Intrinsic (DCF)
Margin of safety
1 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
Insufficient data
Risks
- Piotroski 3/9 — weak financial health
- Altman Z -2.29 — distress zone
- Thin margins at 0.00%
- Negative free cash flow $-36.45M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$0.00$0.00$0.00$154000.00$0.00
Net income$-40.37M$-63.78M$-111.78M$-177.04M$-50.97M
EPS$-3.79
Free cash flow$-36.17M$-53.91M$-83.72M$-153.53M$-36.45M
Profit margin-114,962.34%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CELC$5.80B254.33.05.05.3Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Celcuity LLC trades at $119.00. Our Smart Value Score of 25/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -2.29, it sits in the distress.

Frequently asked questions

What is Celcuity LLC's stock price?
Celcuity LLC (CELC) trades at $119.00.
Is Celcuity LLC overvalued?
Smart Value Score 25/100 (Grade F, Strong Sell).
What is the price target of Celcuity LLC (CELC)?
The analyst target price is $130.55, representing +9.7% upside from the current price of $119.00.
Piotroski F-Score?
3/9 — weak financial health.
Altman Z-Score?
-2.29 — distress.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio
ROE-163.80%
Beta0.42
50D MA$113.87
200D MA$83.21
Shares out0.05B
Float0.03B
Short ratio
Avg volume0.7M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years